We utilized a custom bioinformatic pipeline (TE-Transcripts) to quantify loci-specific expression of HML-2 (123 unique loci) in human gliomas and normal brain in 71 glioma samples (Figure 2). This evidence concerns the gene CLEC10A and central nervous system cancer.